Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Bicalutamide tablets (zhaohuixian)

Combined with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy for the treatment of advanced prostate cancer. More role
App download minus 10 yuan
Common name:
bicalutamide tablets
Product No.:
A14202011866
Approval No.:
Gyzz h20064085 (inquired by the State Drug Administration)
Jianke price:
¥910.00
Product specification:
50mg*30s 50mg*28s 50mg*28s
Manufacturer:
Shanghai Chaohui Pharmaceutical Co., Ltd
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
Related classification
People who browse this product also browse
    Your recent history
      Wechat sweep: Jianke
      Health care doctor
      • Product introduction
      • instructions
      • Qualification certificate
      • Relevant information
      Product name Bicalutamide tablets (zhaohuixian)
      Main raw materials The main component of this product is bicalutamide. Chemical name: (& plusmn;) - N - [4-cyano-3 - (trifluoromethyl) phenyl] - 3 - [(4-fluorophenyl) sulfonyl] - 2-hydroxy-2-methylpropionamide molecular formula: c18h14n2o4f4s molecular weight: 430.37.
      Main role Combined with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy for the treatment of advanced prostate cancer.
      Product specification 50mg*28s
      Usage and dosage 1. Adults: adult males, including the elderly: one tablet (50mg), once a day. The treatment with Zhaohui should start at the same time as LHRH analog or surgical orchiectomy. 2. Children: Zhaohui is prohibited for children. 3. Renal damage: there is no need to adjust the dose for patients with renal damage. 4. Liver damage: there is no need to adjust the dose for patients with mild liver damage, and drug accumulation may occur in patients with moderate and severe liver injury.
      manufacturing enterprise Shanghai Chaohui Pharmaceutical Co., Ltd
      Jianke commitment
      • Genuine guarantee, formal invoice

        Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

      • Private packaging, privacy protection

        When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

      • Efficient logistics and safe arrival

        All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

      • Three warehouses to ensure inventory

        Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

      [drug name] Bicalutamide tablets (zhaohuixian)

      [common name] bicalutamide tablets

      [specification and model] 50mg*28s

      [manufacturer] Shanghai Chaohui Pharmaceutical Co., Ltd

      [drug type] Western medicine

      [approval No.] Gyzz h20064085

      [validity period] 24 months

      [functional indications] Combined with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy for the treatment of advanced prostate cancer.

      [usage and dosage] 1. Adults: adult males, including the elderly: one tablet (50mg), once a day. The treatment with Zhaohui should start at the same time as LHRH analog or surgical orchiectomy. 2. Children: Zhaohui is prohibited for children. 3. Renal damage: there is no need to adjust the dose for patients with renal damage. 4. Liver damage: there is no need to adjust the dose for patients with mild liver damage, and drug accumulation may occur in patients with moderate and severe liver injury.

      [adverse reactions] Zhaohuixian is generally well tolerated, and there are few cases of drug withdrawal due to adverse reactions. 1. It can be reduced with orchiectomy. 2. Severe liver function changes rarely occur, which are often transient. Either continued treatment or immediate discontinuation of treatment can gradually subside or improve (see the section 'precautions'). 3. Liver failure is rare in patients treated with this product, but its causal relationship has not been established. Consideration should be given to checking liver function regularly (see section 'precautions'). Cardiovascular effects such as angina pectoris, heart failure, conduction disorders (including prolonged PR and QT intervals), arrhythmias and nonspecific ECG changes are rarely observed. Thrombocytopenia is rarely reported. See the inner packaging instructions for details.

      [precautions] This product is widely metabolized in the liver. Data suggest that drug clearance may slow in patients with severe liver damage, which may lead to accumulation. Therefore, this product should be used with caution for patients with moderate and severe liver injury. Due to possible liver changes, regular liver function testing should be considered. Major changes generally occur within the first 6 months of treatment. Severe liver function changes are rare in the treatment of this product (see adverse reactions). In case of serious changes, stop the treatment with this product. This product shows inhibition of cytochrome P450 (CYP3A4) activity, so caution should be taken when combined with drugs mainly metabolized by CYP3A4 (see contraindications and drug interactions). See the inner packaging instructions for details. Please read the instructions carefully and follow the doctor's advice.

      [taboo] 1. Zhaohui is forbidden to be used for women and children. 2. Zhaohui can not be used for patients allergic to Zhaohui first. 3. Zhaohui can not be used in combination with terfenadine, astemizole or cisapride.

      [listing Permit Holder] Shanghai Chaohui Pharmaceutical Co., Ltd

      [packaging unit] box

      [main ingredients] The main component of this product is bicalutamide. Chemical name: (& plusmn;) - N - [4-cyano-3 - (trifluoromethyl) phenyl] - 3 - [(4-fluorophenyl) sulfonyl] - 2-hydroxy-2-methylpropionamide molecular formula: c18h14n2o4f4s molecular weight: 430.37.

      [character] This product is a film coated tablet, which appears white or off white after removing the coating.

      [applicable population] adult

      [medication for pregnant and lactating women] This product is forbidden for women, not to mention pregnant women or lactating mothers.

      [medication for children] Please refer to the detailed description in the [usage and dosage] section.

      [medication for elderly patients] Please refer to the detailed description in the [usage and dosage] section.

      [storage] Store tightly at room temperature

      Praise degree

      zero%

        reminder

        Dear customer:

        In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

        Bicalutamide tablets (zhaohuixian)

        ¥910.00

        reminder

        To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

        Please enter the correct verification code!
        Loding...
        Can't see clearly. Change one

        Dear customer:

        Your callback failed this time. Please re-enter the verification code to try. Thank you!